Mj. Kupferminc et al., IMMUNOREACTIVE TUMOR-NECROSIS-FACTOR-ALPHA IS ELEVATED IN MATERNAL PLASMA BUT UNDETECTED IN AMNIOTIC-FLUID IN THE 2ND TRIMESTER, American journal of obstetrics and gynecology, 171(4), 1994, pp. 976-979
OBJECTIVE: We investigated the participation of the cellular arm of th
e immune system in adaptation to pregnancy by assessing plasma and amn
iotic fluid levels of the cytokine tumor necrosis factor-alpha. STUDY
DESIGN: Fifty-five healthy pregnant women who underwent second-trimest
er genetic amniocentesis at a mean gestational age of 17.0+ +/- 1.4 we
eks composed study group A. Blood was drawn from each patient before a
mniocentesis, and an aliquot of amniotic fluid was obtained for this s
tudy. Twenty-one healthy patients at a mean gestational age of 35.5 +/
- 4.8 weeks composed study group B, and blood was obtained from each p
atient at an outpatient prenatal visit. Twenty-two healthy, nonpregnan
t women of reproductive age composed the control group (C). All specim
ens were stored at -70 degrees C and collectively assayed for tumor ne
crosis factor-alpha by a specific enzyme-linked immunoassay. RESULTS:
All patients in group A had a normal karyotype and all patients in gro
ups A and B had uneventful pregnancies. Tumor necrosis factor-alpha wa
s detected in the plasma of 43 of 55 (78.2%) patients in group A compa
red with 7 of 21 (33.3%) patients in group B (p < 0.001); tumor necros
is factor-alpha was not detected in any of the 22 women in group C. Th
e median plasma tumor necrosis factor-alpha level for group A was 135
pg/ml (range 0 to 625 pg/ml) compared with 0 pg/ml (range 0 to 110 pg/
ml) in group B (p < 0.001). Tumor necrosis factor-alpha was not detect
ed in any of the amniotic fluid specimens studied. CONCLUSIONS: Levels
of tumor necrosis factor-alpha were elevated in the plasma but not de
tected in the amniotic fluid of normal pregnant patients in the second
trimester. These findings suggest involvement of the cellular branch
of the immune system and its products, the cytokines, in the normal ad
aptation of the mother to the fetal allograft, with a possible role in
regulating trophoblast growth and invasion.